Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Oncology

Pfizer's New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments

Pfizer's Chris Boshoff outlines plans to prioritize high-return projects, with a focus on obesity, Oncology, and oral GLP-1 therapies, amid Q3 growth.

Benzinga

How Healthcare Leader Clara Latorre is Transforming Dermatology and Oncology Through Strategic Innovation

In today’s fast-paced healthcare world, few leaders balance clinical expertise and strategic innovation as seamlessly as Dr. Clara Latorre.

inkl

3 Healthcare Stocks Leading the Fight Against Global Diseases

As chronic and infectious diseases continue to rise, the demand for advanced healthcare solutions grows. Hence, investing in established healthcare stocks, Pfizer (PFE), Merck & Co (MRK), and AbbVie (ABBV), presents a compelling opportunity to capitalize on the sector’s landscape. Read on….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Undervalued Health-Tech Stocks to Buy for Long-Term Growth

The health-tech industry’s long-term growth is fueled by the growing need for cutting-edge technologies to address critical areas, as well as the demand for personalized medicine. Thus, it could be wise to invest in fundamentally solid health-tech stocks McKesson (MCK), Cardinal Health (CAH), and Zimmer Biomet (ZBH) poised for long-term…

StockNews.com

This Biotech Stock Insider is Buying Shares, Should You?

This Nuvation Bio board member and longtime biotech industry insider carried out his first purchase since his appointment in January.

Barchart

Cancer vaccine breakthrough as tests show positive results on patients with tumours

The jab, known as mRNA-4359, is developed by Moderna

The Independent UK

China detains five AstraZeneca staff over ‘data privacy and import breaches’

Detentions involve Chinese citizens who marketed cancer drugs for firm’s oncology division

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

3 Oncology Stocks With Major Upside

With the rising prevalence of chronic diseases, increasing cell and gene therapies, and rising tech adoption in the biotech industry, the oncology market is booming. Amid this backdrop, investors could consider quality biotech stocks Pyxis Oncology (PYXS), Immatics (IMTX), and Jazz Pharmaceuticals (JAZZ), having significant upside potential. Continue reading.

StockNews.com

As Radiotherapy Redefines Cancer Care, Here's the Stock to Buy Near 52-Week Highs

A new generation of radiotherapies are redefining cancer care, offering the potential for a more powerful treatment with fewer side effects. It could become a mainstream therapy for the big "traditional" cancers that make the disease the leading cause of death worldwide, which is why Morgan Stanley forecast the radiopharma…

Barchart

Man Arrested For Selling Counterfeit Cancer Drugs In Houston

Sanjay Kumar arrested in Houston for selling counterfeit cancer drugs in the U.S., facing serious charges for trafficking in fake oncology medications.

Top News

The future of cancer care: How advanced oncology solutions are changing the industry

Cancer is one of the most devastating diseases, affecting thousands of people every year. That is also why it is one of the most well-researched areas of healthcare, with medical professionals constantly looking for ways to adapt the latest technology developments to improve cancer detection and treatments

inkl

5 Biotech Stocks Under $10 With Multibagger Potential

As the biotech industry continues to redefine the healthcare landscape, here are five penny biotech stocks poised for meteoric growth in this evolving industry.

Barchart

1 Biopharma Stock Setting the New Standard in Cancer Care Drugs

The annual conference of the American Society of Clinical Oncology is always the biggest event-making cancer conference. And this year, the attention-grabber was AstraZeneca, as its lung and breast cancer drugs significantly slowed the spread of disease in two trials, potentially establishing the medicines as the new standard of care…

Barchart

‘Off the charts’: the key breakthroughs giving new hope in treating cancer

World’s largest cancer conference in Chicago shares ‘impressive’ findings in vaccines, drug trials and AI

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Cancer patients say they were turned away from New Mexico hospital

‘They didn’t even try to make it work,’ one oncology patient said of Memorial Medical Center

StockNews.com

3 Pharma Stocks Delivering Exciting April Returns

The pharmaceutical industry is expected to grow rapidly due to the ever-rising healthcare needs, increasing demand for innovative medications, and technological advancements. Therefore, fundamentally strong pharmaceutical stocks Dr. Reddy’s (RDY), Teva Pharmaceutical Industries (TEVA), and AbbVie (ABBV) could be worth adding to your portfolio. Read on.

The Times of India

Advancing cancer care with emerging technology: A fine balance

The breakthroughs in cutting-edge medical technologies for cancer care are remarkable. It seems like every day we are reading about ground-breaking progress that can change the fundamental premise of medical care delivery. Wearable technology, molecular testing and point-of-care devices promise hospital-level care at home, but established technologies like robotic surgery…

Barchart

Up 825% So Far in 2024, Can This Penny Stock Go Any Higher?

Despite its outsized year-to-date gains, Wall Street expects this breakout penny stock to soar 55% higher, on average.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock

Next-generation cancer therapies are here. AstraZeneca - already an oncology leader - is going down the path of radiopharmaceuticals with its purchase of Fusion. Along with the other potential blockbuster drugs in its pipeline, this should bode well for growth at AZN.

StockNews.com

3 Pharma Stocks Fueling Investor Enthusiasm

The pharmaceutical industry is expected to expand rapidly due to growing global healthcare needs and advancements in technology. Therefore, fundamentally strong pharma stocks Merck (MRK), AbbVie (ABBV), and GSK plc (GSK) might be ideal additions to your portfolio. Read on.

The Times of India

Exclusive: 'Radiation therapy is curative in many cancers and has seen significant advancement'

The c-word strikes most people like a thunderbolt, impacting the psyche as a disease with no cure and very dismal chances of survival. Fortunately, recent advancements in medication and technology have significantly increased the survival rate of cancer patients worldwide. Even in cases where cancer is detected at a later…

The Hindu

Oncology Park will help bring down cancer medicine prices, says Rajeeve

Commissioning of Oncology Park in Kerala to reduce cancer medicine prices, boost sales, and achieve ₹1,000 crore turnover.

International Business Times

We've Just Scratched The Surface Of What Vaccines Can Achieve

The rapid development of Covid-19 vaccines was a historic medical triumph. But hastening the end of the pandemic may only be the beginning.

AAP

Telix posts first profit as sales triple to $502m

Melbourne-based radiation oncology business Telix Pharmaceuticals has made its first-ever profit after strong sales for its prostate cancer imaging agent.

The Times of India

'Wonder' drug to treat aggressive form of lung cancer promises hope

A new drug that can increase survival rates and average survival of cancer patients! Seems futuristic, right? Well, researchers at the Queen Mary University London have found a new drug that can work against a difficult-to-treat and aggressive form of cancer, mesothelioma. The findings of the study have been published…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.